Three colleagues of oncology nurse Deborah Diprete acknowledged her potential as a unprecedented healer. Going Above and PastDeborah DiPrete, RN, epitomizes the essence...
Chester Freeman was recognized with bladder most cancers and most not too long ago with continual lymphocytic leukemia (CLL). Learn Chester's blogs right...
ONCT-534, a dual-action AR inhibitor, confirmed a well-tolerated security profile and potential scientific advantages in sufferers with relapsed/refractory mCRPC.Therapy with the investigational, dual-action...
Keytruda plus radiation remedy reveals promising outcomes for breast most cancers sufferers, notably these with TNBC and HR+/HER2- subtypes.Amongst sufferers with triple adverse...
Testosterone restoration might take at the very least six months in sufferers with prostate most cancers who have been handled with androgen deprivation...
